In vitro diagnostic (IVD) market booms as South Koreans favour self-diagnosis
This article was originally published in Clinica
South Korea's in vitro diagnostic test market is undergoing rapid expansion as the popularity of self-diagnosis grows. Local companies are increasingly focusing on R&D in diagnostics rather than pharmaceuticals, since the cost of developing a new test is far lower than that of a new drug, according to Pharma Koreana.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.